Patent · US Active

Prodrugs of phosphonate nucoleotide analogues

US7803788B2 · kind B2 · utility

60Cited by
22References
10Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 28, 2008
Grant dateSep 28, 2010
Priority date
Expiry dateNov 11, 2028

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N33/5011
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

A novel method has led to the identification of novel mixed ester-amidates of PMPA for retroviral or hepadnaviral therapy, including compounds of structure (5a)having substituent groups as defined herein. Compositions of these novel compounds in pharmaceutically acceptable excipients and their use in therapy and prophylaxis are provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.